Current Therapeutic Research-Clinical and Experimental
Impact Factor Trend (2021–2026)
Clarivate IF trend for Current Therapeutic Research-Clinical and Experimental
SCImago Journal Rank citation prestige weighting
50 papers with at least that number of citations each
Aims & Scope
We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific therapies or disease states, and applied health delivery or pharmacoeconomics. CTR encourages and supports the submission of manuscripts describing: • Interventions designed to understand or improve human health, disease treatment or disease prevention; • Studies that focus on problems that are uncommon in resource-rich countries; • Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing); • Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English; • Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
MEDICINE, RESEARCH & EXPERIMENTAL
MEDICINE, RESEARCH & EXPERIMENTAL
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisCurrent Therapeutic Research-Clinical and Experimental (abbr: CURR THER RES CLIN E, ISSN: 0011-393X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Inc. in United States since 1959. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.609 (Q2), an H-index of 50.
The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 30 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $2,911 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics